日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

On the role of antibody affinity and avidity in the IgE-mediated allergic response

抗体亲和力和亲合力在IgE介导的过敏反应中的作用

Bachmann, Martin F; Krenger, Pascal S; Mohsen, Mona O; Kramer, Matthias F; Starchenka, Sviatlana; Whitehead, Piers; Vogel, Monique; Heath, Matthew D

Regulatory T cells define affinity thresholds for CD8(+) T cell tumor infiltration.

调节性 T 细胞决定 CD8(+) T 细胞肿瘤浸润的亲和力阈值

Mohsen Mona O, Josi Romano, Marar Sanjana V, Ghimire Anish, Yang Lan, Krenger Pascal S, Solé Casaramona Arnau, Speiser Daniel E, De Brot Simone, Bachmann Martin F

Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza Viruses.

多功能且可扩展的纳米颗粒疫苗作为对抗新出现的流感病毒的支架。

Pardini Alessandro, Rothen Dominik A, Krenger Pascal S, Vogt Anne-Cathrine, Josi Romano, Liu Xuelan, Tars Kaspars, Kopf Manfred, Vogel Monique, Bachmann Martin F

Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and Specificity.

使用血清型特异性登革病毒样颗粒疫苗进行靶向淋巴结免疫可增强抗体亲和力和特异性。

Rothen Dominik A, Pardini Alessandro, Dutta Sudip Kumar, Krenger Pascal S, Vogt Anne-Cathrine, Josi Romano, Vogel Monique, Engeroff Paul, Mohsen Mona O, Tars Kaspars, Martina Byron, Bachmann Martin F

Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines 2024, 12, 874

更正:Rothen 等人,《新型空间优化 VLP 疫苗对所有四种登革病毒血清型的临床前评价》,Vaccines 2024, 12, 874

Rothen, Dominik A; Dutta, Sudip Kumar; Krenger, Pascal S; Vogt, Anne-Cathrine S; Lieknina, Ilva; Sobczak, Jan M; Osterhaus, Albert D M E; Mohsen, Mona O; Vogel, Monique; Martina, Byron; Tars, Kaspars; Bachmann, Martin F

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies

病毒样颗粒是增强mRNA诱导抗体的有效工具

Vogt, Anne-Cathrine S; Jörg, Lukas; Martina, Byron; Krenger, Pascal S; Chang, Xinyue; Zeltins, Andris; Vogel, Monique; Mohsen, Mona O; Bachmann, Martin F